NCT02382354View on ClinicalTrials.gov

Remifentanil for the I-gel and Laryngeal Mask Airway Insertion

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Supraglottic Airways for General Anesthesia
Interventions
DRUG

remifentanil

The predetermined effect-site concentration of remifentanil was started using modified Dixon's up-and-down method

DEVICE

i-gel

I-gel insertion was inserted 5 min after anesthesia induction

DEVICE

laryngeal mask airway

laryngeal mask airway insertion was inserted 5 min after anesthesia induction

DRUG

propofol

Anesthesia was induced with propofol target-controlled infusion at the effect-site concentration of 5 μg/ml

Trial Locations (1)

443-721

Ajou University hospital, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT02382354 - Remifentanil for the I-gel and Laryngeal Mask Airway Insertion | Biotech Hunter | Biotech Hunter